Category: Medications - Page 5

Learn how to check your Medicare drug coverage tiers and spot formulary changes that could raise your medication costs. Essential guide for seniors managing prescriptions.

A shared medication calendar helps families and caregivers coordinate doses, avoid dangerous interactions, and prevent missed pills. Learn how to set one up with the right tools and avoid common mistakes.

Media coverage often fuels mistrust in generic drugs despite scientific proof they're just as safe and effective as brand-name versions. Learn how news stories shape perceptions and what you can do to make informed choices.

Medication synchronization (med sync) aligns all your chronic meds to one monthly refill date, cutting missed doses and improving adherence. Studies show it boosts adherence by 3-8%, reduces hospitalizations, and is free at most pharmacies.

Aspirin is no longer recommended for most people to prevent first heart attacks or strokes. Learn who should avoid daily doses and why bleeding risks now outweigh the benefits, based on 2026 guidelines.

Clinicians are raising alarms about generic drug quality, especially those made overseas. New data shows higher adverse event rates linked to manufacturing location - and the system isn't keeping up.

Authorized generics are brand-name drugs sold without the brand label, identical in every way to the original. They're a strategic response to patent expiration, lowering prices while helping manufacturers retain market share.

HER2-positive breast cancer is now highly treatable with targeted therapies like trastuzumab, T-DXd, and tucatinib. Learn how these drugs work, their side effects, and why newer options are changing survival rates.

The Orange Book is the FDA's official guide to therapeutic equivalence between brand-name and generic drugs. Learn how TE codes determine if generics can be safely substituted-and why it matters for your health and wallet.

Gene therapy offers revolutionary cures but brings hidden dangers when combined with other drugs. From immune reactions to delayed cancers, the safety risks are unique-and we're still learning how to manage them.